Polycystic Ovary Syndrome (PCOS) and COVID-19: An Overlooked Female Patient Population at Potentially Higher Risk During the COVID-19 Pandemic

    July 2020 in “ BMC Medicine
    Ioannis Kyrou, Emmanouíl Karteris, Tim Robbins … Harpal Randeva
    Studysummary This review discusses how overlapping risk factors in women with polycystic ovary syndrome may heighten their risk for severe COVID-19, advocating for integrated care approaches but provides no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on bmcmedicine.biomedcentral.com →
    Discuss this study in the Community →

    Research cited in this study 9

    1. Androgen Sensitivity Gateway to COVID-19 Disease Severity Drug Development Research · 2020
    2. Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19? Journal of Cosmetic Dermatology · 2020
    3. A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity Journal of Cosmetic Dermatology · 2020
    4. Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist? International Journal of Endocrinology · 2020
    5. Ethnicity, Obesity, and the Prevalence of Impaired Glucose Tolerance and Type 2 Diabetes in PCOS: A Systematic Review and Meta-Regression Human Reproduction Update · 2018
    6. Vitamin D Receptor Polymorphisms and Polycystic Ovary Syndrome: A Systematic Review Journal of Obstetrics and Gynaecology Research · 2017
    7. Diagnosis and Management of Polycystic Ovary Syndrome (PCOS) Springer eBooks · 2015
    8. Prevalence of Androgenic Alopecia in Patients with Polycystic Ovary Syndrome and Characterization of Associated Clinical and Biochemical Features Fertility and Sterility · 2014
    9. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004

    Related research 7

    1. The Impact of Hirsutism and Hypertrichosis on the Psychological State of Women with Polycystic Ovary Syndrome and Hyperandrogenism Applied Psychology Research · 2024
    2. Correlation of Clinical and Biochemical Hyperandrogenism in Thai Women with Polycystic Ovary Syndrome Journal of Obstetrics and Gynaecology Research · 2016
    3. Hyperandrogenism in Women: Polycystic Ovary Syndrome Hanyang Medical Reviews · 2012
    4. Polycystic Ovary Syndrome and Acne Skin therapy letter · 2011
    5. Hirsutism Scoring in Polycystic Ovary Syndrome: Concordance Between Clinicians' and Patients' Self-Scoring Fertility and Sterility · 2010
    6. Diagnosis of Hyperandrogenism: Clinical Criteria Best Practice & Research Clinical Endocrinology & Metabolism · 2006
    7. Spironolactone Therapeutic Effect in the Hyperandrogenism Syndrome Problemy e̊ndokrinologii · 1993